RXO Inc
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 4 days.
- Recent price momentum is +100.0% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 4.7% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 14:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation C+
How expensive the stock is versus earnings, sales and its own 5-year history.
| Forward P/E | 78.9x | Better than 4% |
| Price / Sales | 0.7x | Better than 85% |
Growth C+
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 6.2% | Better than 51% |
| Net income CAGR (3Y) | -54.7% | Better than 2% |
| Free cash flow CAGR (3Y) | 55.7% | Better than 86% |
Profitability D+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 14.4% | Better than 11% |
| Operating margin | -0.1% | Better than 21% |
| Net margin | -1.7% | Better than 23% |
| Return on equity | -6.3% | Better than 22% |
| Return on invested capital | -3.1% | Better than 24% |
Momentum A+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 25.4% | Better than 98% |
| 6-month return | 16.0% | Better than 79% |
| 12-month return (ex latest month) | 150.7% | Better than 98% |
| Distance below 52-week high | 5.5% | Better than 94% |
Financial Health B-
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.3x | Better than 32% |
| Debt to assets | 20.4% | Better than 55% |
| Interest coverage | -2.3x | Better than 20% |
| Free cash flow / net income | 625.0% | Better than 94% |
Analyst View D-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 25.0% | Better than 11% |
| Upside to average target | 5.8% | Better than 9% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 28.60
- Open
- 28.45
- Day range
- 28.24 - 28.78
- Avg price
- 28.41
- Volume
- 6.19M
- Turnover
- 176.00M
- Turnover ratei
- 4.58%
- Volume ratioi
- 1.55
- Amplitudei
- 1.89%
- 52-week rangei
- 11.18 - 29.90
Valuation
- P/Ei
- -47.90
- P/E (TTM)i
- -54.35
- P/Bi
- 3.07
- EPSi
- -0.59
- Book value / shi
- 9.19
- Net profit
- -97.32M
- Net assets
- 1.52B
Share structure
- Market cap
- 4.66B
- Float capi
- 3.83B
- Shares out
- 164.95M
- Float sharesi
- 135.38M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2022-10-27
5.5% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-36.78M net over the window
Short interest
- Shares short
- 7.79M
- % of floati
- 4.72%
- Days to coveri
- 2.16
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of RXO Inc (RXO)?
RXO Inc last traded at 28.26. This page shows a periodic quote snapshot. Check the displayed quote time.
What is RXO Inc's market cap?
About 4.66B.
What is the P/E ratio of RXO Inc?
The trailing twelve-month P/E is -54.35. The Valuation tab shows it against the stock's own five-year range.
Does RXO Inc pay a dividend?
RXO Inc does not currently pay a regular dividend.
Is RXO Inc a buy according to analysts?
The consensus of 12 analysts is a Buy rating, with an average 12-month price target of 29.90, which implies 5.8% upside from the current price. This is not investment advice.
What is RXO Inc's StockVane Quant Rating?
The StockVane Momentum strategy currently rates RXO Inc a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
RXO Inc discussion 0 comments